Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $2.8 billion.

  • Takeda Pharmaceutical's Short-term Investments rose 534.48% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 534.48%. This contributed to the annual value of $2.3 billion for FY2025, which is 210309.58% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Short-term Investments of $2.8 billion as of Q4 2025, which was up 534.48% from $2.5 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Short-term Investments ranged from a high of $2.8 billion in Q4 2025 and a low of $101.8 million during Q1 2024
  • For the 5-year period, Takeda Pharmaceutical's Short-term Investments averaged around $1.8 billion, with its median value being $2.2 billion (2021).
  • In the last 5 years, Takeda Pharmaceutical's Short-term Investments crashed by 3702.39% in 2022 and then skyrocketed by 216039.29% in 2025.
  • Takeda Pharmaceutical's Short-term Investments (Quarter) stood at $2.0 billion in 2021, then dropped by 3.91% to $1.9 billion in 2022, then dropped by 6.31% to $1.8 billion in 2023, then surged by 43.36% to $2.6 billion in 2024, then rose by 5.34% to $2.8 billion in 2025.
  • Its Short-term Investments stands at $2.8 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.3 billion for Q2 2025.